Delivery Order SPE2DB22D3301-SPE2DB25FY8JB
Award Date 7/24/25
Potential Completion Date 7/25/25
Potential Value $63K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,311.62 on September 15, 2025, for Otezla 20 mg tablets (60-count supply). This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of September 16, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Otezla is a prescription medication used primarily to treat psoriasis, psoriatic arthritis, and behçet's disease. This...
- The Defense Logistics Agency awarded a delivery order valued at $16,471.83 to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by June 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Otezla is a pharmaceutical treatment commonly used for psoriasis, psoriatic arthritis,...
- The Defense Logistics Agency awarded a delivery order valued at $5,085.83 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Otezla is a prescription medication used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis, supporting...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for Otezla 30 mg tablets in a quantity of 60 units, valued at $15,493.97. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025. This non-set-aside delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Otezla (apremilast) is a immunosuppressive medication commonly used to treat psoriasis and...
- The Defense Logistics Agency awarded a delivery order valued at $4,576.65 to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count supply) on July 24, 2025, with a completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Otezla is a prescription immunosuppressant medication used to treat various inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $18,874.86 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 20, 2025, with a completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60 count) with a ceiling value of $33,215.61 under a firm fixed-price arrangement. This contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-set-aside, competitively awarded procurement. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,691.01 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, a pharmaceutical product commonly used to treat psoriasis and psoriatic arthritis. This competitively awarded, firm fixed-price delivery order was executed on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $16,991.63 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 15, 2025. The delivery order was issued on September 12, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $30,038.24. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion on September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...